3. Syndrome of joint pain and
loss of form and function
caused by generally
progressive loss of
articular cartilage
accompanied by
attempting to repair of
articular cartilage,
remodeling and sclerosis of
subchondral bone,
formation of subchondral
bone cysts and osteophytes
12. World wide prevalence: 1-3%
Age distribution: all 4F:1M
Peak onset: (35-50)
It can affect any age from childhood
up to the age of 75
Life expectancy is reduced by
approximately 7 yrs (♂) 3 yrs (♀)
Due to
Cardiovascular disease
Infection
Renal disease
Respiratory disease
Vasculitis
Malignancy
GI disease
13. HLA class II is
strongly linked to
RA.
HLA DR4- , most
common, HLA DR1 and
HLA DW15
Genetically linked
50-70 % of Caucasian RA patients are
HLA DR4, Compared to 20-25 % of the
population at large.
1st degree relatives of RA patients are 4x
25 % frequency in identical twins
5 % Frequency in non-identical twins
21. No definitive test
Symptoms mimic other autoimmune
disease
22.
23.
24. 40 yo women
c/o fatigue, anorexia, weakness
for 6 months
Difficult to ambulate on rising
from bed, but better after 30 mins
Stiffness and pain in wrists,
fingers, compromising manual
dexterity
Swelling in joints of fingers
Physical exam
Knees swollen, tender and limited
ROM in knees and hips
Knees and wrist were warm no
erythema
Proximal interphalangeal joints of
both hands were warm and enlarged
with nonbony fusiform swelling
Two small nonpainful subcutaneous
nodules along proximal ulna of left
arm
X-rays: soft tissue swelling, joint
effusion, juxta-articular osteopenia
Synovial fluid aspirated- low viscosity,
clear yellow color, WBC with 50%
neutrophils, no crystals, no bacteria
25. HLA-DR4 positive
Rheumatoid factor positive titer of 1:
500
Erythrocyte sedimentation rate-
increased
Serum cyclic citrullinated protein
(CCP) antibodies- positive
Family history- sister with arthritis,
right hip prosthetic replacement
40yo obese white woman with deep,
achy, poorly localized pain in right hip
and knee
Similar symptoms as sister
Bony, nonpainful swellings along the
medial aspect of two distal
interphalangeal (DIP) joints of each
hand. Erythrocyte sedimentation rate
was normal
Synovial fluid- viscosity normal, clear
yellow, minimal WBC and neutrophils,
no crystals
RF negative CCP negative
X-ray narrowing of the joint space,
subchondral bone sclerosis, subchondral
cysts and osteophytes
26. In DJD- found in the distal
interphalangeal joints, are bony and
not symmetric
RA- the proximal interphalangeal
and metacarpophalangeal joints
27.
28. Successful interprofessional
treatment of juvenile rheumatoid
arthritis: A case report
Integrative Medicine April 2017
9 yo boy- symptoms started at 2
years of age
29. Aquatic exercise for the treatment of
hip and knee osteoarthritis
Physical Therapy- July 2017
Conservative treatment: medication,
education, weight loss, exercise
Aquatic exercise- 32C-36C/ 90-97F
Reduce pain and stiffness and cause
muscle relaxation
1 hour session twice a week for 3
months
Warm-up, lower limb ROM,
strengthening, and stretching
exercises, balance and coordination
exercise and general cardiovascular
conditioning
30. Critical review: Vegetables and fruit
in the prevention of chronic diseases
European Journal of Nutrition 2012
Fruits and veggies provide:
nutrients, dietary fiber,
phytochemicals
Chronic diseases: obesity, T2DM,
HTN, CHD, CVA, cancer, IBD, RA,
COPD, asthma, osteoporosis, eye
disease and dementia
Increased intake of fruits and
veggies decreases risk of chronic
diseases and decreases severity of
chronic diseases
31. Boeing, H., Bechthold, A., Bub, A., Ellinger, S., Haller, D., Kroke, A., … Watzl, B.
(2012). Critical review: Vegetables and fruit in the prevention of chronic diseases.
European Journal of Nutrition, 51, 637–663.
Boothby, J., & Turnbull, T. (2017). Successful interprofessional treatment of
juvenile
rheumatoid arthritis: A case report. Integrative Medicine, 16(2), 55–60.
Franco, M. R., Morelhao, P. K., de Carvalho, A., & Pinto, R. Z. (2017). Aquatic
exercise
for the treatment of hip and knee osteoarthritis. Physical Therapy, 97(7), 693–697.
Rosenberg, A. E. (2013). Bones, Joints, and Soft Tissue Tumors. In V. Kumar, A. K.
Abbas, & J. C. Aster, Robbins Basic Pathology (pp. 765-797). Philadelphia: Elsevier
Saunders.
Editor's Notes
RANK/L- receptor activator for nuclear factor- kB/ L ligand
TNF member, expressed by osteoblasts and marrow stromal cells, activation of the transcription factor NF-kB, which drives the expression of genes that stimulate osteoclast formation, fusion, differentiation, function and survival
OPG- osteoprotegerin- blocks action of RANKL, produced in bone, hematopoietic marrow and immune cells
Bone Signaling and RANKL
Bone metabolism is dynamic, balances bone formation and resorption
Bone resorption- performed by active osteoclast, stimulated by RANKL in normal process and stimulated by PTH in pathologic process
Bone formation
Performed by inhibiting osteoclasts and stimulating osteoblasts- OPG inhibits osteoclasts
Osteoclast activation
Stimulates bone resorption, by RANKL (ligand) secreted by osteoblasts and binds to the RANK receptor on osteoclast precursor and mature osteoclast cells
PTH- secreted by cancer cells- is activated by its receptor stimulates adenylyl cyclase, binds to cell surface receptors on osteoblasts to stimulate production of RANKL and M-CSF
IL1- stimulates osteoblast differentiation and thus bone resorption
Vitamin D- stimulates RANKL expression
Prostaglandin E2- activates adenylyl cyclase and stimulates resorption
IL6 and MIP-1A
Osteoclast inhibition decreases bone resorption
OPG- osteoprotegerin- mimics receptor produced by osteoblasts and stromal cells that binds to and sequesters RANKL, and inhibits osteoclast differentiation, fusion and activation
Calcitonin- interacts directly with the osteoclast via cell surface receptors
Estrogen- via decrease in RANKL, stimulates bone production (anabolic) and prevents resorption, and inhibits activation of adenylyl cyclase
Transforming growth factor beta due to increase in OPG
IL 10- suppresses osteoclasts
1. The primary articular defect in osteoarthritis.- degeneration of the articular cartilage, structural changes in the underlying bone are secondary
Mainly a degenerative disorder of articular cartilage in which the chondrocytes respond to biomechanical and biologic stresses in a way that results in breakdown of the matrix-
Insidious with age and without apparent initiating cause (primary osteoarthritis)
Joints: hands, knees, hips, spine
Secondary osteoarthritis- a predisposing condition (trauma, developmental deformity or underlying systemic disease-, hemochromatosis or marked obesity, almost common in athletes
Annual costs $33billion
Most common joint disorder and is part of aging and important cause of physical disability in people over 65
Articular cartilage- along with the synovial fluid it provides virtually friction free movement within the joint and in weight bearing joints, it spreads the load across the joint surface in a manner that allows the underlying bones to absorb shock and weight
To do this the cartilage must be elastic and have tensile strength (proteoglycans and type II collagen are produced by chondrocytes)
Chondrocyte function is key to maintain cartilage synthesis and degradation- imbalance leads to osteoarthritis
Factors affecting chondrocyte- mechanical stresses, aging, genetic factors (polymorphisms and mutations in genes encoding components of the matrix and signaling molecules, contribute to osteoarthritis susceptibility) increased bone density, sustained high estrogen levels
Imbalance in the expression, activity and signaling of cytokines and growth factors results in degradation and loss of matrix
Early- degenerating cartilage containing more water and less proteoglycan, type II collagen network also decreased, chondrocyte apoptosis is increased
Cartilage tensile strength and resilience are compromised- chondrocytes proliferate and attempt to repair the damage by synthesizing new collagen and proteoglycans
Matrix changes and chondrocyte loss eventually predominate
Early: alterations in the composition and structure of the matrix, chrondrocytes have limited capacity to proliferate- some divide to form small clones of cells that secrete newly synthesized matrix
Vertical and horizontal fibrillation and cracking of the matrix occur as the superficial layers of the cartilage are degraded
Chondromalacia or the softening articular cartilage and granulation occurs on the surface
Full thickness portions of the cartilage are lost and the subchondral bone plate is exposed and smoothened and burnished by friction, looking like polished ivory (bone eburnation)
The underlying cancellous bone becomes reinforced by osteoblastic activity
Small fractures can dislodge pieces of cartilage and subchondral bone into the joint, forming loose bodies (joint mice)
The fracture gaps allow synovial fluid to be forced into the subchondral regions to form fibrous walled cysts. Mushroom shaped osteophytes develop at the margins of the articular surface
in severe disease- a fibrous synovial pannus covers the peripheral portions of the articular surface
Insidious- 50-60 years
Deep, aching pain exacerbated by use, morning stiffness, crepitus (grating or popping sensation in the joint) and limitation in ROM
Osteophyte impingement on spinal foramina can cause nerve root compression with radicular pain, muscle spasms, muscle atrophy, and neurologic deficits
Heberden nodes in finger, represent prominent osteophytes at the distal interphalangeal joints- common in women
With time joint deformity can occur
TX: based on symptoms with possible joint replacement
Presence of osteophyte, reduced joint space, sclerosis
1st- relieve pain, improve muscle strength and conditioning
Maintain independence, mobility, quality of life
Start with non pharm- move to OTC- move to pharm, PO, topical, injection intra-articular corticosteroid injections
Education
Physical therapy and activity- exercise, ROM, weight loss
Braces/ orthotics
Acupuncture
Yoga and massage
causes severe joint destruction
is a systemic disease with systemic damage
leads to disability
Is associated with significant costs
Is an immune mediated disease driven by inflammatory cytokines
What is synovium- thin delicate lining that serves as an important nutrients for cartilage, synthesize joint lubricants (hyaluronic acid), collagens, fibronecting that make the structural framework of the synovial interstitium
RA causative factors is like the Bermuda Triangle- genetic, autoimmune and environmental factors- smoking, diet, weight,
HLA-human leukocyte antigen- major role in adaptive immune response,
Genetic factors-
50% is due to genetics
Linked to the HLA-DRBI locus
Polymorphism in the PTPN22 gene- that inhibits T cell activation
Citrullinated peptide- helps in citrullination, which is a normal process required for normal skin formation and other physiologic functions, in RA and autoimmune response develops against citrullinated peptides detected as anti-citrullinated peptide antibodies (ACPA)
Detection of these antibodies detects anti-cyclic citrullinated peptides (Anti-CCP) currently the most commonly used diagnostic test. They are present in 98% of patients with RA
T cell activation proliferate and secrete cytokines IL-2, TNF, IL4
B cell activation and autoantibodies activated by T cells B cells and plasma cells found in rheumatoid synovium plasma cells activate rheumatoid factor production and anticitrullinated peptide antibodies mainly IgM antibodies that recognize the
Fc portion of IgG, and IgA and attack
Macrophage activation- that cause the majority of the damage, produce proinflammatory cytokines (TNF, IL 1,6, 8)- which stimulate fibroblasts and osteoclasts. Macrophages produce prostaglandins and leukotriences, NO, and other proinflammatory mediators with local and systemic effects
The synovial fibroblast secretes cytokines (IL 6, 8 proteases and collagenases)
Neutrophils also invade the space and is found in the synovial fluid
Chondrocytes contribute to the dissolution of their own cartilage matrix causing progressive narrowing of joint spaces
TNF is the cytokine in the inflammatory cascade, affecting the levels of other proinflammatory and anti-inflammatory cytokines
Activates monocytes/ macrophages inflammation
Activates chondrocytes releasing collagenases cartilage breakdown
Activates osteoclasts suppresses osteoblasts bone resorption and erosions
This is a snap shot of the pathogenesis of a very complex disease
Before the onset of RA, a smooth synovial membrane is just a few cells thick and produces synovial fluid, which lubricates and nourishes a joint.
Rheumatoid arthritis can causes white blood cells to attack healthy synovium.
The white blood cells release cytokines (proteins) that prompt the synovial membrane’s blood vessels to multiply. This change is referred to as hypervascularization.
The increased blood flow leads to excess tissue growth. The synovial cells reproduce at an abnormally fast rate, causing the synovium to thicken.
The synovial membrane develops microscopic projections called villi on its surface. This makes the tissue rough and uneven.
The thickening tissue requires space, and it invades the small space between the joint’s bones. This invasion causes the pannus to cover the surface the bones and their articular cartilage.
Pannus is Latin for cloth or garment
It is abnormal tissue that contains blood vessels and covers up a normal body structure, it invades the space between a joint’s bone, covering the bones and the protective layer for articular cartilage
What does the pannus do?
Excess fluid production- causing swelling and pain, fluid contains damaged proteins that degrade joint tissue
Cartilage destruction- lysosomes breakdown the matrix metalloproteinases (MMP) and degrade cartilage
Bone destruction- filled with osteoclasts that destroy faster than can replace bone cells,
The synovial tissue becomes inflamed
Pannus tissue forms
Cartilage and other joint tissues are damaged
tender, warm, swollen joints
Symmetrical pattern of affected joints
Joint inflammation often affecting the wrist and finger joints closest to the hand
Joint inflammation sometimes affecting: neck, shoulders, elbows, hips, knees, ankles and feet
Fatigue, fever, malaise
Pain and stiffness lasting more than 30 minutes in the morning or after long rest
Diseases’- SLE, systemic sclerosis, psoriatic arthritis, polymyalgia rheumatica
American College of Rheumatology (ACR) and European League Against Rheumatism
Early detection is critical
No longer need to see rheumatoid nodules, symmetric joint symptoms or joint erosion on x-ray- which are late features
Serology- none to definitively diagnose, but do detect changes in the body indicative of RA
Rheumatoid factor- measure presence
Anti-cyclic citrullinated peptide (ACPA or anti-CCP)
Inflammatory markers: erythrocyte sedimentation rate (ESR), C- reactive protein (CRP)
Goals of therapy are to attain symptomatic relief of disease activity including the swelling and tenderness of joints, as well as the pain patients with active RA experience.
Improving the physical function and physical capabilities of the patient.
Thirdly, advanced therapies should intervene in slowing the progression of the disease.
Early aggressive treatment to decrease disease activity and prevent joint damage
Medications: NASIDS, corticosteroids (prednisone), disease modifying antirheumatic drugs (DMARDS)- methotrexate, biologics that suppress immune system activity Humera, Enrel, Remicade and Janus kinase (JAK) inhibitor- the newest drug
Non pharm- yoga, tai-chi, anti- inflammatory diet high in omega 3 fatty acids
No osteophytes and sclerosis
HX: lumbar puncture, medications, joint injections, growth hormone, blocked spinous process of cervical spine
His upper body did not support his trunk, hip movement was restricted and quadriceps were atrophied
Treatment focused on increasing breathing capacity and increasing awareness and connection with his body
He underwent extensive physical therapy for years and had been effective in increasing mobility and motion
At 10 years of age- bilateral hip replacement
Post op- chiropractic care, physical therapy, and other non surgical medical interventions
He had a progressive slow and steady climb for 2 years
The normal, healthy growth of this patient’s bone, joint, muscle and nervous structure was a multidisciplinary approach to include: chiropractic, naturopathic, acupuncture, orthopedics, physical therapy, rheumatology, that reduced inflammation, increased the load bearing capacity and allowed the body to heal itself
At age 17 regularly plays golf, and basketball
I chose this case study for 2 reasons-
Moving to Florida, I now have a pool and noticed many others do also and many have pool heaters, many people can do the recommended exercises in their own pool, if they have mobility issues without having to go to the physical therapist or doctor, they can lower the risk of OA by using their own backyard pool
In 2012 I broke my hip in a vehicle roll-over in Afghanistan, I was med-evac’ed back to the States, I was fortunate that I need not require surgery, but extensive physical therapy to include aquatic therapy
At first glance, it looks really easy, right get in the water and move your legs up and down while holding onto the wall
The true is always worse, it hurt, but hurt so good, I will never joke about the seniors at the YMCA that do aquatic exercises again.
3 months of PT, and continuation on my own, I completed a half marathon, 18 months after the accident
Based on 5 a day or 650gm of veggies and fruit less than a quarter of people consume this daily
RA risks: genetic predisposition, smoking, obesity and nutrition contribute to disease
Increased consumption of red meat, protein and coffee increase
Oily fish and olive oil decrease
Most studies show a reduced risk at high consumption of fruits and veggies
Greater botanical variety in fruit and veggies intake associated with less inflammation
Some provide special protective effects against various cancers like squamous cell lung carcinoma
Phytochemicals reduces the inflammatory response, also cellular redox processes as well as endothelial and metabolic processes